The trial aimed to evaluate whether a combination of the sFlt-1/PlGF ratio and the fullPIERS algorithm, by classifying patients with suspected or diagnosed preeclampsia as low risk for adverse outcomes and therefore suitable for expectant management, would safely lead to a reduction in preterm deliveries. Here, PGF is linked to preeclampsia.